98,755 XNAS Volume
XNAS 24 Mar, 2025 1:13 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Christine Mikail Cvijic | President and CFO | Sale of securities on an exchange or to another person at price $ 16.94 per share. | 13 Mar 2025 | 4,501 | 72,343 | - | 16.9 | 76,247 | Common Stock |
| Rachel McMinn | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 20.40 per share. | 22 Nov 2024 | 47,500 | 1,297,859 | - | 20.4 | 969,000 | Common Stock |
| Christine Mikail Cvijic | President and CFO | Purchase of securities on an exchange or from another person at price $ 20.48 per share. | 22 Nov 2024 | 24,000 | 76,844 | - | 20.5 | 491,400 | Common Stock |
| Cory Freedland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 7,700 | 7,700 | - | - | Stock Option (Right to Buy) | |
| Robert Keith Woods | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 7,700 | 7,700 | - | - | Stock Option (Right to Buy) | |
| Sarah B. Noonberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 7,700 | 7,700 | - | - | Stock Option (Right to Buy) | |
| Rohan Palekar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 7,700 | 7,700 | - | - | Stock Option (Right to Buy) | |
| Robert A. Baffi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 7,700 | 7,700 | - | - | Stock Option (Right to Buy) | |
| Christine Mikail Cvijic | President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 53,900 | 53,900 | - | - | Employee Stock Option (Right to buy) | |
| Stuart Cobb | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 34,450 | 34,450 | - | - | Stock Option (Right to Buy) | |
| Stuart Cobb | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 20,391 | 20,391 | - | 0 | Common Stock | |
| Rachel McMinn | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 93,282 | 93,282 | - | - | Employee Stock Option (Right to buy) | |
| Christine Mikail Cvijic | President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 31,903 | 52,844 | - | 0 | Common Stock | |
| Cory Freedland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 15,400 | 15,400 | - | - | Stock Option (Right to Buy) | |
| Robert Keith Woods | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 15,400 | 15,400 | - | - | Stock Option (Right to Buy) | |
| Sarah B. Noonberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 15,400 | 15,400 | - | - | Stock Option (Right to Buy) | |
| Rohan Palekar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 15,400 | 15,400 | - | - | Stock Option (Right to Buy) | |
| Robert A. Baffi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 15,400 | 15,400 | - | - | Stock Option (Right to Buy) | |
| Julie Jordan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) |